Literature DB >> 23240297

[Systemic and oropharyngeal side effects of inhaled corticosteroids].

T S Rochat1, J-P Janssens.   

Abstract

The use of inhaled corticosteroids (ICS) is an important component of asthma management. Although their main impact is on airway inflammation, ICS are not devoid of systemic side effects (adrenal insufficiency, osteoporosis, brittle skin, ocular effects, growth retardation). Oropharyngeal side effects are also reported. These effects appear dose and duration dependent. They also vary according to the type of ICS used, its method of administration and drug interactions. It is recommended to titrate ICS to the lowest effective dose, to regularly reconsider their indication and to be aware of drug interactions. In addition, a change in ICS may have a favorable impact on side effects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23240297

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  1 in total

1.  Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury.

Authors:  Nan Li; Dong Weng; Shan-Mei Wang; Yuan Zhang; Shan-Shan Chen; Zhao-Fang Yin; Jiali Zhai; Judy Scoble; Charlotte C Williams; Tao Chen; Hui Qiu; Qin Wu; Meng-Meng Zhao; Li-Qin Lu; Xavier Mulet; Hui-Ping Li
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.